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ABSTRACT
Monocytes differentiate into osteoclasts through stimulation of receptor activator of NF-kB (RANK). Many downstream effectors of RANK
play a positive role in osteoclastogenesis, but their relative importance in osteoclast differentiation is unclear. We report the discovery
that activation of a single pathway downstream of RANK is sufficient for osteoclast differentiation. In this regard, introduction of
constitutively activated IKKb (IKKb
SSEE) but not wild-type IKKb into monocytes stimulates differentiation of bona fide osteoclasts in the
absence of RANK ligand (RANKL). This phenomenon is independent of upstream signals because IKKb
SSEE induced the development of
bone-resorbing osteoclasts from RANK and IKKa knockout monocytes and in conditions in which NEMO-IKKb association was inhibited.
NF-kB p100 and p105, but not RelB, were critical mediators of this effect. Inflammatory autocrine signaling by tumor necrosis factor a
(TNF-a) and interleukin 1 (IL-1) were dispensable for the spontaneous osteoclastogenesis driven by IKKb
SSEE. More important, adenoviral
gene transfer of IKKb
SSEE induced osteoclasts and osteolysis in calvariae and knees of mice. Our data establish the sufficiency of IKKb
activation for osteolysis and suggest that IKKb hyperactivation may play a role in conditions of pathologic bone destruction refractory to
RANK/RANKL proximal therapeutic interventions.  2010 American Society for Bone and Mineral Research.
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Introduction
B
one balance depends on the concerted activity of osteo-
blasts, bone-forming cells, and osteoclasts, bone-resorbing
cells. In pathologic conditions such as rheumatoid arthritis and
osteoporosis, bone balance favors increased osteoclast activa-
tion,
(1) resulting in bone pain and increased fracture risk.
Therefore, therapies that target the osteoclast are useful in these
conditions.
(2) On the other hand, gene mutations that disrupt
osteoclast differentiation lead to development of osteopetrotic
bones that compromise bone homeostasis.
(3) Undoubtedly, inc-
reasing understanding of the factors that regulate the osteoclast
in health and disease will offer important insight into new
therapies for bone loss associated with pathologic conditions
and for osteopetrosis.
The osteoclast differentiates from monocyte precursors throu-
gh the action of ligand for the receptor activator for NF-kB
(RANKL) and macrophage colony-stimulating factor (M-CSF).
(1) On
stimulation of their cognate receptors, RANK and c-Fms, a series of
signaling events induces activation of transcription factors such as
NF-kB, AP-1, and NFATc1, which results in fusion of precursors and
expression of genes required for osteoclast function, including
b3-integrin, cathepsin K, tartrate-resistant acid phosphatase (TRACP),
and matrix metalloproteinase 9 (Mmp9).
(4) With expression of all
necessary genes for osteoclast differentiation, the ability of the
osteoclast to resorb bone requires tight regulation of the actin
cytoskeleton. Genetic murine models have revealed a number of
proteins whose activity is required for cytoskeletal regulation
and bone resorption.
(5–9) These molecules contribute to form-
ation of the actin ring, the signature of a polarized, bone-
resorbing osteoclast.
(10)
The complement of proteins that are important for osteoclast
differentiation makes up a growing list, but their relative import-
ance remains unclear. A well-studied family of transcription factors
that is required for osteoclastogenesis is NF-kB. NF-kBp 1 0 0a n d
p105 are both required together for osteoclast differentiation.
(11)
Additionally, p65/RelA
(12) and RelB
(13) have been shown to play
complementary roles in osteoclast survival and differentiation,
respectively. Therefore, factors that activate NF-kBa r el o g i c a l
targets for the treatment of osteoclast-mediated disease.
The IkB kinase (IKK) complex activates NF-kB downstream of
RANK. Upstream signals lead to association of two catalytically
active kinases, IKKa and IKKb, with the noncatalytic member
IKKg/NEMO. This association is required for activation of IKK
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1282through phosphorylation of two IKK activation-loop serines. IKK
then phosphorylates IkB, targeting it for proteasomal degrada-
tion and allowing NF-kB to enter the nucleus and regulate gene
transcription.
(14–16) Pharmacologic inhibition of the IKK associa-
tion with NEMO abrogates osteoclastogenesis and inflammatory
osteolysis.
(17,18) Furthermore, mice devoid of IKKa
(19) or IKKb
(20,21)
demonstrate an impaired ability for osteoclast development in
vitro. Moreover, mice lacking IKKb displayed osteopetrosis and
resistance to inflammatory bone erosion, whereas mice lacking
active IKKa showed no skeletal phenotype.
(20) This finding
implicates IKKb as an important target for therapy in osteoclast-
mediated disease.
We now report that IKKb is not only necessary for RANKL-
mediated osteoclastogenesis, but its activation also is sufficient
for osteoclast formation. Using retroviral delivery of constitu-
tively active IKKb (IKKb
SSEE), we reveal a signal for differentiation
of functional osteoclasts that occurs downstream of, but inde-
pendentfrom,RANK.IKKb
SSEE,butnotwild-typeIKKborIKKa
SSEE,
induces osteoclast differentiation from monocytes. This phe-
nomenon depends on NF-kB but does not require NEMO, IKKa,
or RelB. Finally, adenoviral gene transfer of IKKb
SSEE in knees
and calvariae of mice is sufficient for development of massive
osteolysis. Our findings demonstrate for the first time that a
single activated kinase is sufficient for RANK-independent osteo-
clast differentiation and that active IKKb induces osteolytic
disease. These data highlight the centrality of IKKb in osteoclast
differentiation and implicate hyperactivation of IKKb in patho-
logic bone destruction.
Materials and Methods
Animals and cells
All mice were housed in a controlled barrier facility at Washing-
ton University (St Louis, MO, USA). TRACP-Cre mice
(22) were from
Dr Roodman (University of Pittsburgh, PA, USA). Floxed IKKb
(23)
mice were from Dr Pasparakis (University of Cologne, Germany).
TRACP-Cre floxed/floxed IKKb mice were generated by crossing
TRACP-Cre transgenic mice with floxed IKKb mice. IKKa hetero-
zygous mice
(24) were obtained from Dr Akira (Osaka University,
Japan). RelB knockout
(25) and control bone marrow was from
Dr Novack (Washington University, St Louis, MO, USA). RANK
knockout
(26) and control spleens, as well as NF-kB double-
knockout
(27) and control spleens were provided by Dr Xing
(University of Rochester Medical Center, Rochester, NY, USA) For
in vivo experiments, wild-type C57BL/6 mice at 5 to 6 weeks of
age were used.
Plasmids
pMxs retroviral expression plasmid was from Dr T Kitamura
(University of Tokyo, Japan). Mouse cDNA for IKKa was kindly
provided by Dr Kenneth Marcu (Stony Brook, NY, USA). IKKb and
RelBcDNAwerepurchasedfromATCC(Manassas,VA). RelAcDNA
was provided by Dr C Sasaki (NIA, Baltimore, MD, USA). All
expression constructs were subcloned into pMxs using standard
techniques. The following mutations were generated using the
QuickChange II Site Directed Mutagenesis Kit (Stratagene, La
Jolla, CA, USA) with primer pairs in parentheses: IKKb
SSEE
(IKKb_S177_181E_f, GAGCTGGATCAGGGCGAACTGTGCACGGA-
ATTTGTGGGGACTCTGC, and IKKb_S177_181E_r, GCAGAGTCCC-
CACAAATTCCGTGCACAGTTCGCCCTGATCCAGCTC); IKKb
WWAA
(IKKb_W739_741A_f, GACTCTAGACGCGAGCGCGTTACAGATG-
GAGGATG, and IKKb_W739_741A_r, CATCCTCCATCTGTAAC-
GCGCTCGCGTCTAGAGTC); IKKb
KM (IKKb_K44M_f, GTGAACA-
GATCGCCATCATGCAATGCCGACAGGAGC, and IKKb_K44M_r,
GCTCCTGTCGGCATTGCATGATGGCGATCTGTTCAC); and IKKa
SSEE
(IKKa_S176_180E_f, GATGTTGATCAAGGAGAGCTCTGTACAGAA-
TTTGTGGGAACATTGC, and IKKa-S176_180E_r, GCAATGTTCCCA-
CAAATTCTGTACAGAGCTCTCCTTGATCAACATC). Note that the
constitutive activating effect of the mutation of IKKb was
established previously.
(28,29)
Generation of monocytes/macrophages
Marrow was flushed from long bones into a minimum essential
medium (a-MEM). Spleens and day 18.5 fetal livers were crushed
into cell suspensions in a-MEM and were centrifuged at 453 rcf.
Cell pellets were resuspended in whole medium [a-MEM with
1  penicillin/streptomycin, 10% heat-inactivated fetal bovine
serum (FBS)]. Monocytes/macrophages were produced by
growing cell suspensions in the presence of 10ng/mL of
M-CSF. Monocytes/macrophages were allowed to proliferate for
3 days at 378Ci n5 %C O 2, at which point they were infected with
retrovirus (50% virus supernatant, 50% a-MEM containing 10%
FBS, 10ng/mL of M-CSF, 100U penicillin/100mg strep per Liter,
and 4mg/mL hexadimethrine bromide). Twenty-four hours after
infection, cells were selected in a-MEM containing 10% FBS,
10ng/mL of M-CSF, 100U penicillin/100mg strep per Liter, and
2mg/mL puromycin for 72 hours, at which point selection
medium was removed, and cells were washed and grown for 24
additional hours without puromycin. At this point, cells were
lifted, counted, and plated for downstream experiments.
Generation of retrovirus
The use of Plat-E retrovirus packaging cells stably expressing
retroviral structural proteins gag-pol and env for transient
production of high-titer retrovirus was described previously.
(30)
Briefly, 8mg of pMx vectors expressing our gene of interest was
transfected into 5 million Plat-E cells (grown in DMEM
supplemented with 10% FBS, 10ng/mL of M-CSF, and 100U
penicillin/100mg strep per Liter) using Fugene 6 (Roche, Palo
Alto, CA, USA) according to manufacturer’s instructions. Twenty-
four hours after transfection, the medium was exchanged to
remove the transfection reagent. Then 24 and 48 hours after
medium exchange, supernatant was collected and pooled for
infection of monocytes (see above).
In vitro osteoclastogenesis
For osteoclastogenesis assays, 3 10
4 monocytes were plated in
200mLo fa-MEM with 10% FBS. IKKb
SSEE-expressing cells were
cultured in 10ng/mL of M-CSF, whereas GFP- and IKKb
WT-
expressing cells werecultured in10ng/mL ofM-CSF plus 100ng/
mL of RANKL for 4 days. At this point, cells were fixed and TRACP
stained using the Leukocyte Acid Phosphatase Kit (Sigma, St
Louis, MO, USA). TRACP
þ cells with three or more nuclei were
scored as osteoclasts.
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For inhibition of osteoclastogenesis, cells were treated with
100ng/mL of OPG/Fc chimera (R&D Systems, Minneapolis, MN,
USA), 25mM TAT-NBD (YGRKKRRQRRR-G-TTLDWSWLQME) or
25mM of TAT–mutant NBD (YGRKKRRQRRR-G-TTLDASALQME)
during the entire course of retroviral transduction and in vitro
osteoclast differentiation.
RNA isolation and cDNA production
RNA was isolated from macrophage or osteoclast cultures using
the Total RNA Isolation Mini Kit (Agilent Technologies, Santa
Clara, CA, USA) according to manufacturer’s instructions. Reverse
transcription was described previously.
(21)
Real-time quantitative PCR
The real-time quantitative PCR (qPCR) procedure was described
in detail previously.
(21)
Western blotting
The Western blot procedure was described previously.
(21) One
million cells were used for protein extraction and demonstration
of protein expression.
Coimmunoprecipitation
One million cells expressing GFP, flag IKKb
WT, flag IKKb
WA, flag
IKKb
SSEE, or flag IKKb
SSEE/WA were lysed in immunoprecipitation
(IP) buffer [10mM Tris, pH 7.4, 150mM NaCl, 0.5% NP-40
(IGEPAL), 1mM EDTA, 1mM NaF, 1mM PMSF, 1mM Na3VO4, and
1  protease inhibitor cocktail] at 48C. Protein was measured by
BCA Assay (Pierce, Rockford, IL, USA) and normalized. Non-
specific binding was removed by rocking total cell lysate at
48C with GammaBind G Sepharose beads (GE Lifesciences,
Piscataway, NJ) and 100ng of normal mouse IgG for 2 hours at
48C. Beads and normal antibody were centrifuged, and super-
natant was incubated with GammaBind G Sepharose beads and
1mg/mL of mouse anti-Flag M2 antibody (Sigma) in a total of
700mL of IP buffer and 1  protease inhibitor cocktail at 48C for
16 hours. Immune complexes were centrifuged with beads.
Supernatant was removed by vacuum suction, and 2  sample
buffer [0.5M Tris-HCl, pH 6.8, 10% (w/v) SDS, 10% glycerol, 0.05%
(w/v) bromphenol blue, 3% b-mercaptoethanol, and distilled
water] was added to the beads, which were boiled for 5minutes
to elute the complex components, which were analyzed by
Western blot.
Kinase assay
Plat-E cells expressing indicated flag-tagged IKKb constructs
were lysed in IP buffer. IKKb was immunoprecipitated with M2
antibody,washedtwicewithIPbufferandoncewithkinaseassay
buffer (Cell Signaling Technologies Danvers, MA, USA), and
incubated for 30 minutes at 308Ci n3 0mL of kinase assay buffer
with 1mg GST-IkBa, 2.5mM MgCl2, and 16mM ATP. The reaction
was terminated with 30mL of reducing sample buffer. Samples
were analyzed by Western blot.
Bone-resorption assays
Osteoclasts were cultured on 5mm
2 100-mm-thick dentin slices
for 5 days in a 48-well tissue culture plate. To visualize resorption
pitsandtracks,slices wereexposedto0.5NNaOH,andcellswere
removedbymechanicalagitation.SliceswerewashedinPBSand
stained with 0.1% toluidine blue (w/v) in PBS. Stained slices were
rinsed with PBS and blotted dry, and pits were visualized by
light microscopy. Resorption of artificial matrix was described
previously.
(21)
Actin ring staining
Cells were fixed in 4% paraformaldehyde in PBS for 5minutes at
room temperature. Fixed macrophages or osteoclasts on dentin
slices were washed with PBS and permeabilized in 0.2% Triton
X-100 in PBS for 10minutes at room temperature. Dentin slices
were washed with PBS and then incubated in a 1:40 dilution of
Alexa Fluor-488 phalloidin (Invitrogen Molecular Probes, Eugene,
OR, USA) for 10 minutes in a dark, humidified chamber at room
temperature. Slices were washed with PBS and mounted onto
microscope slides for visualization of actin rings with fluorescent
microscopy.
Generation and use of adenovirus
Adenovirus expressing IKKb
SSEE was generated by subcloning
from the pMx parental vector into Ad5 CMV K-NpA Shuttle using
EcoR1 andNot1 restriction endonucleases(NewEngland Biolabs,
Ipswich, MA, USA). Recombination,
(31) production, and char-
acterization [plaque-forming units (pfus)/particle] of virus were
provided by Viraquest, Inc. (North Liberty, IA, USA). For local in
vivo gene transfer in mice, 1 10
7 pfus of virus diluted in 10mL
of sterile PBS were injected intraarticularly into the knee joint
capsule. Contralateral knees on the same mouse served as
experimental (Ad IKKb
SSEE) and control (Ad ntLacZ). Five mice
were used for these experiments with comparable results. For
calvarial osteolysis, 1 10
7 pfus of virus diluted in 50mL of sterile
PBS were injected supracalvarially. Lipopolysaccharide (LPS)
(10mg)orRANKL(4mg)dilutedin50mLtotalvolumeofPBSwere
injected as positive controls. For calvarial experiments, five mice
were used for each condition (virus, RANKL, and LPS) with
comparable results. In vivo injections were executed with
100-mL insulin syringes with 29G needles. Seven days after
injection, knees and calvariae were fixed, decalcified, and
analyzed histologically for osteoclasts and osteolysis.
Histology
Bones were collected from mice and fixed in 10% buffered
formalin for 24 hours. Bones then were decalcified for 7 days in
buffer consisting of [14% (w/v) EDTA and H4NOH, pH 7.2],
dehydratedinethanol(30%to70%),clearedthroughxylene,and
embedded in paraffin. Sections were stained histochemically
for TRACP to visualize osteoclasts or hematoxylin and eosine
(H&E) to assess tissue architecture. Immunohistochemistry was
1284 Journal of Bone and Mineral Research OTERO ET AL.performed according to the antibody manufacturer’s instruc-
tions for immunoperoxidase staining.
Microscopy
Cells and histologic sections were imaged under white or
ultraviolet (UV) light on an inverted microscope (Olympus IX-51).
For f-actin visualization, UV light was passed through an FITC
filter cube to localize green phalloidin. Digital images were
captured using a CCD camera (Olympus DP70, 12-megapixel
resolution).
Statistics
Student’s two-tailed t test for comparison between means was
used for all analyses.
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Constitutively active IKKb induces RANKL-independent
osteoclast differentiation from monocytes
We and others have demonstrated the necessity for IKKb in
osteoclast differentiation.
(20,21) In an effort to identify mutations
in IKKb that could prevent or enhance its ability to rescue
osteoclast differentiation in cells lacking IKKb, we made the
observation that constitutively activated IKKb (IKKb
SSEE), but not
the wild-type (IKKb
WT) form, in wild-type or IKKb knockout bone
marrow–derived macrophages induced the formation of
osteoclasts in the absence of RANKL (Fig. 1A). Levels of IKKb
WT
and IKKb
SSEE protein were comparable (Figure 1B), whereas
IKKb
SSEE, but not IKKb
WT, was recognized by an antibody specific
for IKKb phosphorylated at activation-loop serines (Fig. 1C),
suggesting that the kinase domain of IKKb
SSEE exists in an active
conformation and that mutation of IKKb activation-loop serines
177 and 181 to glutamic acid, and not overexpression of IKKb,i s
responsible for the formation of osteoclasts in the absence of
RANKL.
Further characterization showed that IKKb
SSEE induced exp-
ression of RelB and c-fos, which are important for normal
osteoclast differentiation.
(13,32) IKKb
SSEE, but not IKKb
WT, also
induced the expression of b3-integrin and cathepsin K, two
markers for mature osteoclasts whose products are required for
bone resorption
(6,33) (Fig. 1C). Real-time qPCR analysis revealed
that IKKb
SSEE also induced expression of calcitonin receptor,
cathepsin K, TRACP, and b3-integrin (Fig. 1D). Furthermore,
IKKb
SSEE-induced osteoclasts form actin rings and resorb artificial
(not shown) and authentic bone matrix (Fig. 1A). Expression of
IKKb
SSEE by RANKL-independent osteoclasts was demonstrated
using IKKb
SSEE-GFP fusion construct (not shown). These data
provide evidence that the TRACP
þ multinucleated cells induced
through expression of constitutively active IKKb in macrophages
are authentic osteoclasts.
Next, we sought to examine whether stimulation of osteoclast
differentiation through introduction of IKKb
SSEE was a phenom-
enon restricted to precursors obtained from adult tissue. To this
end, IKKb
SSEE- infected, but not GFP- or IKKb
WT-infected, fetal
liver cells formed authentic osteoclasts with visible actin rings
that resorbed dentin (not shown). Actin rings and resorption pits
were observed in IKKb
WT-infected cells only after RANKL admi-
nistration (not shown). These observations reveal that IKKb
SSEE is
sufficient to induce an authentic program for functional
osteoclasts from adult and fetal precursor cells independent
of RANKL. To verify the specificity of the osteoclastogenic effect
of the phosphomimmetic mutation, wemutated IKKb activation-
loop serines to alanine (IKKb
SSAA) and lysine to methionine
(IKKb
KM), respectively. These mutations resulted in an activation-
deficient molecule that failed to rescue RANKL-induced osteo-
clastogenesis in IKKb knockout monocytes (Fig. 1E, F). Therefore,
phosphomimmetic mutation of IKKb activation-loop serines is a
specific inducer of the osteoclast program, and inactivating the
kinase domain of this molecule hinders its osteoclastogenic
activity.
IKKb
SSEE Rescues RANK Knockout Osteoclast Phenotype
Having established that RANKL is dispensable for IKKb
SSEE-
mediated osteoclastogenesis, we tested whether intrinsic RANK
signaling played a role in this phenomenon by using the RANKL
decoy molecule osteoprotegerin (OPG-Fc)
(10,34) and RANK-null
cells. OPG-Fc completely inhibited RANKL-induced osteoclasto-
genesis in IKKb
WT -infected macrophages but had no effect on
IKKb
SSEE-inducedosteoclastdifferentiation,indicatingthatIKKb
SSEE
induces osteoclastogenesis without RANKL (Fig. 2A). Furthermore,
IKKb
SSEE, but not IKKb
WT nor GFP, induced the formation of
osteoclasts from RANK knockout cells (Fig. 2B). Importantly, RANK
knockout macrophages expressing GFP or IKKb
WT failed to form
osteoclasts in response to RANKL (Fig. 2B). IKKb
SSEE- induced
osteoclasts also formed actin rings and resorbed dentin (Fig. 2C).
Consistent with this result, Western blot revealed that IKKb
SSEE
introduction into, but not RANKL treatment of, RANK knockout
cells resulted in expression of c-fos and RelB, as well as c-src, b3-
integrin, and cathepsin K (Fig. 2D), indicating that IKKb
SSEE-ind-
uced RANK knockout osteoclasts are indeed bona fide osteo-
clasts. Real-time qPCR supported this conclusion (Fig. 2E).
Therefore, IKKb
SSEE functions independent of RANK to induce
differentiation of functional osteoclasts.
Fig. 1. IKKb
SSEE induces bona fide osteoclasts from bone marrow, spleen, and fetal liver progenitors. (A) Bone marrow macrophages from IKKb knockout
and littermate mice were infected with retroviruses expressing GFP, IKKb
WT, or IKKb
SSEE and cultured with M-CSF alone or M-CSFþRANKL for 4 days (as
described under ‘‘Materials and Methods’’) and were TRACP stained to visualize osteoclasts. Arrows denote osteoclasts. Lower panels, quantification;
flx¼loxP flanked. For bone resorption, fetal liver cells (FLCs) were plated on dentin slices to determine bone resorption. After 5 days, slices were stained
with toluidine (Tol.) blue and phalloidin to visualize resorption tracks (darker areas) and actin ring formation, respectively. Cells were cultured in M-CSF
alone except where indicated. Quantification of percent resorbed area was done using Bioquant. Percent resorption area of dentin slices for each
condition is denoted. (B) Expression levels of IKKb
WT and IKKb
SSEE in control and IKKb knockout macrophages were measured by Western blot using anti-
IKKb antibody. Expression of endogenous NEMO is shown as control. (C) Spleen cells were plated as detailed under ‘‘Materials and Methods.’’ After 3 days,
cellswereinfectedwiththevarious pMxvirusesas indicated. Cellsexpressingtheviralproteinswereselectedwithpuromycinfor2 to3 days. Westernblot
for expression ofNF-kBmoleculesandosteoclastmarkersin totalcelllysatesofspleencellsinfectedwith theindicatedviruseswasperformedusingequal
amounts of total proteins. Actin expression indicates equal loading. OCþ¼osteoclast positive control total cell lysate. (B, C) pMx¼retroviral expression
vector. (D) Relative expression of mRNA for osteoclast markers by real-time qPCR. mRNA was extracted from cells infected with the indicated viruses.
Relative expression of the indicated osteoclast marker genes was determined using specific primers outlined under ‘‘Materials and Methods.’’ GAPDH
served as internal standard for cDNA normalization. Values are expressed as relative quantity plus standard error of the mean. (E) Control and IKKb
knockoutmonocytesweretransducedwithvirusesexpressingGFPortheindicatedformsofIKKb[active(SSEE)andinactive(KM,SSAA)forms].Thesecells
weretreatedwithM-CSFandRANKLandTRACPstained.( F)WesternblottodemonstrateexpressionoftheindicatedIKKbconstructs. Parallelcellstreated
as shown in panel E were lysed and subjected to Western blots with IKK and actin antibodies.
1286 Journal of Bone and Mineral Research OTERO ET AL.IKKb
SSEE acts independently of the classical IKK complex
to drive osteoclastogenesis
Activation of IKKb by upstream signals requires its association,
via two carboxyl-terminal tryptophans (W739 and W741), with
NEMO.
(35,36) Since IKKb
SSEE induces osteoclastogenesis indepen-
dent of RANK, we tested whether IKKbSSEE also could induce
osteoclastogenesis in the absence of NEMO binding. First, we
determined that while administration of cell-permeable NBD
peptides, which inhibit the association of IKKb with NEMO,
blocks RANKL-induced osteoclast differentiation, NBD did
not inhibit osteoclastogenesis in response to transduction of
IKKb
SSEE (Fig. 3A). Second, while mutations of W739 and W741 to
alanine in the presence of the S177 and S181 to glutamic acid
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SSEE/WA) prevent IKKb
SSEE from binding to NEMO (Fig. 3B, C),
IKKb
SSEE/WA is still capable of inducing RANKL-independent
osteoclastogenesis (Fig. 3D). This quadruple IKK mutant is exp-
ressed properly and retains its kinase activity (Fig. 3E, F). These
results solidify the conclusion that IKKb
SSEE induces RANKL-
independent osteoclastogenesis without binding to NEMO,
uncoupling the mechanism of IKKb
SSEE-induced osteoclastogen-
esis from all known upstream stimuli important for osteoclast
differentiation. This suggests that in the setting of osteoclast
differentiation, IKKb binding to NEMO is important only for IKKb
activation-loop phosphorylation, after which point the associa-
tion is not required.
Based on these results, we hypothesized that IKKb
SSEE could
induce osteoclastogenesis without the classical IKK complex,
which includes IKKa, a kinase that is required for osteoclasto-
genesis in vitro.
(19) We confirmed that IKKa null fetal liver–
derived macrophages (FLCs) do not differentiate into osteoclasts
(Fig. 4A) and fail to express mRNA for osteoclast markers in
response to RANKL stimulation (Fig. 4C). However, transduction
of IKKa null FLCs with IKKb
SSEE restores osteoclastogenesis in the
absence of RANKL, restores actin rings and bone resorption
(Fig. 4A, phalloidin and tol. blue, respectively), and induces
expression of typical signaling proteins (Fig. 4B) and expression
of mRNAfor osteoclast markers (Fig.4C).These data indicate that
formation of the classical IKK complex and the IKKa-mediated
noncanonical NF-kB signaling pathway are not a requirement for
IKKb
SSEE to stimulate RANK-independent osteoclastogenesis.
Requirement for coordinated NF-kB Activation in
IKKb
SSEE-Induced Osteoclastogenesis
To identify the mechanism underlying IKKb
SSEE-induced osteo-
clastogenesis, we examined the status of essential NF-kB
subunitscomparedwithRANKL-treatedconditions. Weobserved
elevated levels of RelB in the cytosol of IKKb
SSEE-expressing cells
at all time points assessed, including nonstimulated, compared
with GFP- and IKKb
WT-expressing cells. We also observed redu-
ced levels of IkBa that coincided with an increased level of RelA
protein in the nucleus in the absence of RANKL stimulation and
at all time points tested in IKKb
SSEE- compared with GFP- and
IKKb
WT-expressing cells, indicating that the constitutively acti-
vated form of IKKb induces continuous IkBa processing (Fig. 5A).
These data suggest that IKKb
SSEE acts through an NF-kB-
dependent mechanism to induce osteoclast differentiation. To
test this, we challenged RelB knockout cells with IKKb
SSEE
because we observed induction of RelB protein expression in
response to IKKb
SSEE in macrophages and because RelB expres-
sion is required for RANKL-induced osteoclast differentiation in
vitro and for stimulated but not basal osteoclast formation in
vivo.
(13) RelB knockout bone macrophages were capable of diff-
erentiating into TRACP
þ osteoclasts that express cathepsin K in
the absence of RANKLwhen expressing IKKb
SSEE (Fig.5B, C).Real-
time PCR revealed that while induction of expression of mRNA
for calcitonin receptor and TRACP in response to RANKL was
impaired in RelB null cells, IKKb
SSEE rescued the induction to
levels equivalent to that in wild-type cells expressing IKKb
SSEE
(Fig. 5D). Therefore, IKKb
SSEE does not require RelB to induce
osteoclast differentiation.
Given the observation that IKKb
SSEE induces nuclear transloca-
tion of RelA and induces increased expression of RelB, we further
explored the possibility that these NF-kB subunits mediate
the IKKb
SSEE effect. However, overexpression of RelA, RelB, or a
combination of RelA and RelB (Fig. 5F) did not induce osteoclast
differentiation. To verify activity of the RelA and RelB, we obs-
erved that RelA induced expression of IkBa and that RelA
and RelB alone or in combination induced expression of p100
(Fig. 5E). These results indicate that IKKb
SSEE is a specific activator
of NF-kB capable of inducing osteoclast differentiation and
that ectopic overexpression of RelA and RelB is insufficient to
coordinate this effect.
Phosphorylation of T-loop residues is a hallmark of activation
for many kinases.
(37) Given the specificity of IKKb activation as a
mediator of osteoclast differentiation, we asked whether constit-
utive activation of other kinases through phosphomimmetic
mutations also could induce osteoclast differentiation. IKKa and
IKKb share significant primary and secondary structural homo-
logy,
(15) so we reasoned that in contrast to other kinases,
constitutive activation of IKKa through phosphomimmetic mut-
ation would be most likely to induce an osteoclast program like
IKKb
SSEE. We found that when expressed at comparable levels
(Fig. 5E), IKKb
SSEE induces osteoclast differentiation from
macrophages, whereas IKKa
SSEE had no such effect (Fig. 5F),
demonstrating that IKKb is the specific kinase activator of the
osteoclast program.
It has been established that a combination of both NF-kB1/
p50 and NF-kB2/p52 subunits is required for osteoclast
differentiation.
(11) We tested whether IKKb
SSEE-induced RANK-
independent osteoclastogenesis also requires NF-kB1 and -2 by
transducing control and NF-kB1
 / /NF-kB2
 /  (NF-kB double-
knockout) spleen macrophages with GFP, IKKb
WT, and IKKb
SSEE
Fig. 2. IKKb
SSEE-induced osteoclastogenesis does not require RANKL/RANK upstream signals. (A) Equal number of macrophages (30,000 cells/well) were
cultured in the presence of M-CSF with or without RANKL, each in the absence or presence of OPG/Fc chimera. IKKb
SSEE- expressing cells were cultured
with M-CSF in the absence or presence of OPG/Fc chimera. Cultures were carried out as described under ‘‘Materials and Methods.’’ Cells were stained with
TRACP to visualize osteoclasts. (B) Wild-type, RANK
þ/?,o rRANK
–/– spleen-derived macrophages were infected with a retrovirus expressing GFP, IKKb
WT,o r
IKKb
SSEE.ThesecellswereculturedinthepresenceofM-CSFaloneorincombinationwithRANKLfor4daysandstainedwithTRACPtovisualizeosteoclasts.
(C) Wild-type and RANK
 /  spleen-derived macrophages were infected with a retrovirus expressing IKKb
WT or IKKb
SSEE. These cells were cultured in the
presence of M-CSF alone or in combination with RANKL on dentin and were stained with phalloidin or toluidine (Tol.) blue to visualize actin rings and
resorption pits, respectively. Scale bars indicate relative magnification. Resorbed areas were quantified using Bioquant and expressed as percent area. (D)
Anequalnumberofwild-type(þ/þ)orRANKknockout( / )spleencellsinfectedwiththeindicatedviruseswereculturedinthepresenceofM-CSForM-
CSFþRANKL (RL), and an equal number of total cell lysates were analyzed by Western blot for expression of the indicated proteins. The lower panel
represents real-time qPCR for RANK mRNA in wild-type and RANK knockout cells. (E) Relative expression of mRNA for osteoclast markers assessed by real-
time qPCR. GAPDH served as internal standard normalization. Values are expressed as relative quantity plus SEM.
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absence of RANKL administration. While control cells expressing
IKKb
SSEE produced a significant number of osteoclasts capable
of resorbing bone coinciding with expression of mRNA for
cathepsin K, no osteoclasts were observed in NF-kB double-
knockout cells (Figure 5H,I) despite constitutive IkBa processing
(not shown). We conclude that IKKb
SSEE-mediated induction of
osteoclastogenesis requires NF-kB-mediated gene regulation.
Fig. 3. IKKb
SSEE induces osteoclastogenesis independent from NEMO association. (A) Bone marrow macrophages were transduced with IKKb
SSEE in the
continuous presence of NBD, mutant NBD (mNBD), or vehicle. Cells expressing IKKb
WT were treated with RANKL in the absence of NBD or in the presence
of NBD or mNBD. After 4 days, cells were stained with TRACP. Right panel shows quantification of osteoclasts per well from quadruplicate wells and four
independent experiments. (B) Schematic diagram of IKKb constructs used in panels C and D. Kinase¼kinase domain; LZ¼leucine zipper; HLH¼helix-
loop-helix; NBD¼NEMO-binding domain. Not shown to scale. (C) Cells transduced with the various IKKb forms were lysed. A portion of the lysates was
used as a total cell lysate (TCL) to examine expression of IKK and NEMO proteins. Another portion of the lysate was precleared with gamma beads and
subjectedtoimmunoprecipitationusinganti-Flagantibody.ThecoimmunoprecipitationofIKKandNEMOdepictstheabilityoftryptophan739and741to
alanine mutations to prevent binding of IKKb
WT and IKKb
SSEE to NEMO (as shown in lanes annotated WA and SSEE/WA). (D) Cells transduced with the
indicatedIKKbforms(showninpanelB)wereplatedin theabsenceofRANKLfor4days.CellsthenwerestainedwithTRACPtodetectosteoclasts.IKKb
SSEE
and IKKb
SSEE/WA generated comparable numbers of osteoclasts per well (157 and 169 cells, respectively). (E) Luciferase assay for NF-kB induction by
constructs shown in panel B. Cells were transduced with the indicated IKK forms, and lysates were subjected to luciferase assay, as described under
‘‘Material and Methods.’’ ( F) Lysates identical to those shown in panel E were subjected to IKK kinase. Expression levels of IkB, phosphorylated IkBa (p-
IkBa), and IKKb are shown.
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establishment of in vivo osteolysis
To determine the relevance of IKKb hyperactivation in vivo, we
injected mice with adenovirus expressing IKKb
SSEE or LacZ
supracalvarially or intraarticularly into the knee joint (Supple-
mental Fig. 1). While LacZ did not induce an osteoclast response
in either calvariae or knees, IKKb
SSEE stimulated a massive local
osteolytic response in both settings characterized by bone
destruction and the appearance of osteoclasts at sites of bone
erosion (Fig. 6A, B). To support the role of the kinase activity of
IKKb in mediating this effect, joints injected with adenoviral
IKKb
SSEE showed intense immunostaining for phosphorylated
IkBa at sites of osteoclastic articular bone erosion, whereas LacZ-
infected knees stained negatively for articular osteoclasts and
phosphorylated IkBa (Fig. 6B).
Discussion
We provide evidence that osteoclast differentiation can be
triggered by an autonomous intracellular signal downstream yet
independent of RANK. IKK has been implicated in RANKL-
induced osteoclastogenesis,
(17–21) but the sufficiency of this
single enzyme to independently induce osteoclastogenesis is
surprising. The explanation for this phenomenon is likely to
involve complex signal regulation that mimics NF-kB activation
by RANKL. It is also possible that IKKb
SSEE takes on functions not
performed by IKKb in normal settings. In support of this, we
observe that infection of monocytes with IKKb
SSEE results in
activation of p100 NF-kB (JO and YA, unpublished observations),
which is usually considered to be a function of IKKa.
(38) Perhaps
atypical functions such as this contribute to its osteoclastogenic
activity. Nevertheless, the ability of IKKb
SSEE to induce the
osteoclast depends on kinase activity because mutation of the
ATP-binding lysine to methionine in the kinase domain abro-
gated the IKKb
SSEE osteoclastogenic function (Fig. 1E and
Supplemental Fig. 2).
Differentiation of the osteoclast requires NF-kB.
(11) To deter-
mine whether the phenotype we observed also requires NF-kB,
we tested the ability of IKKb
SSEE to drive osteoclastogenesis in
NF-kB1/2 double-knockout monocytes, in which it failed. In add-
ition to NF-kB, other transcription factors may play a role in the
IKKb
SSEE effect. Interestingly, we observed expression of NFATc1
protein, the master regulator of osteoclastogenesis,
(39) induced
byIKKb
SSEEinmonocytes(SupplementalFig.3).WhetherNFATc1
is required for osteoclastogenesis induced by active IKKb or
whether IKKb controls NFATc1 activity directly in the differ-
entiating osteoclast is unknown.
NF-kB is also a critical regulator of inflammatory signals,
(40)
and inflammatory cytokines enhance osteoclast function.
(41,42)
Since tumor necrosis factor a (TNF-a) and interleukin 1 (IL-1)
induce osteoclast differentiation in certain settings,
(43) and since
we observed both TNF-a and IL-1b expression by monocytes
transduced with IKKb
SSEE (JO and YA, unpublished observations),
Fig. 4. IKKb
SSEE induction of osteoclasts does not require IKKa.( A) Wild-type and IKKa null FLCs expressing GFP were cultured in M-CSF with or without
RANKL or IKKb
SSEE with M-CSF alone. TRACP stain was used for osteoclasts, phalloidin stain for actin rings, and toluidine (Tol.) blue stain for dentin
resorption. Wild-type cells infected with IKKb
SSEE generated 133 22 osteoclasts per well compared with 112 12 osteoclasts per well in IKKb1 null cells
infected with IKKb
SSEE. Percent resorbed area was 22% 5& and 21& 7%, respectively. Scale bars indicate magnification of actin image. (B) Western blot
for expression of NF-kB pathway markers. OC
þ¼osteoclast-positive control; n.s.¼nonspecific band. (C) Relative expression of mRNA for markers of
osteoclastogenesis by real-time qPCR. Levels normalized to GAPDH.
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were required for IKKb
SSEE to induce osteoclast differentiation.
Using IKKb
SSEE-transduced TNF-a or IL-1 receptor knockout
monocytes, we found that TNF-a and IL-1 are not required for
IKKb
SSEE to accomplish its effect in osteoclast differentiation (JO
and YA, unpublished observations). Therefore, IKKb
SSEE- induced
osteoclastogenesis in vitro is uncoupled from inflammatory
signalingwithrespect toTNF-aandIL-1.Nevertheless, giventhat
IKKb
SSEE does induce secretion of these factors, we must
consider the possibility that this kinase modulates osteoclast
Fig. 5. IKKb
SSEE induction of osteoclastogenesis requires coordinated NF-kB signaling. (A) Western blot for expression of NF-kB signaling molecules in
totalcelllysates(leftpanel)andcytosolandnuclearfractions(rightpanel)ofspleenmacrophagesexpressingGFP,IKKb
WT,orIKKb
SSEEnottreatedortreated
with RANKL for the indicated times. (B) TRACP stain of wild-type and RelB knockout cells expressing IKKb
SSEE cultured in the presence of M-CSF without
RANKL (osteoclasts are marked with arrowheads). Number of osteoclasts for wild-type cells was 115 21 cells per well compared with 101 28 cells per
well for RelB knockout cells. (C) Western blot for the indicated proteins in wild-type and RelB knockout cells expressing GFP, IKKb
WT, or IKKb
SSEE cultured
with M-CSF. OC
þ¼osteoclast-positive control. (D) Relative mRNA expression of selected osteoclast markers in wild-type and RelB knockout cells treated
with RANKL or expressing IKKb
SSEE not treated with RANKL. (E, F) Protein expression and osteoclastogenesis, respectively, were measured following
expression of GFP, IKKb
WT, IKKb
SSEE, IKKa
SSEE, p65 (RelA), RelB, or p65þRelB in bone marrow macrophages cultured with M-CSF. (G–I) Control or NF-kB
double-knockout spleen cells transduced with GFP, IKKb
WT, or IKKb
SSEE were analyzed to determine (G) protein expression levels, (H) osteoclastogenesis
and bone resorption, and (I) cathepsin K mRNA expression. Cells in panel I were cultured in M-CSF without RANKL.
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the nature of which will be investigated in future studies.
Consistent with our in vitro findings, adenoviral gene-transfer
experiments revealed that IKKb
SSEE is sufficient for the establish-
ment of osteolysis invivo. Theclinical significance of our findings
is highlighted by our observations that IKKb
SSEE-induced osteo-
clastogenesis is refractory to intervention with OPG and deletion
of RANK/RANKL. In this regard, a number of conditions in human
patients are associated with heightened bone turnover in the
setting of inflammation for which a cause has not been
identified.
(44) Given the potency with which activated IKKb
induces osteoclast appearance and bone destruction in this
model, it is important to consider IKKb activation as an inde-
pendent cause and a target in therapy for conditions of
inflammatory bone destruction.
Our data highlight the critical role of IKKb in osteoclast
differentiation and osteolysis. We have found that constitutively
active IKKb unfolds the osteoclast program in the absence of
upstream signals. We report the first evidence of RANK-
independent osteoclast differentiation that is induced through
a single kinase, and we propose that hyperactivation of human
IKKb may lead to diseases resulting in bone destruction that
would be refractory to treatments targeting receptor–proximal
signaling molecules.
Fig. 6. Active IKKb is sufficient for osteolysis. (A) Images of TRACP-stained histologic slides of calvarial bones of mice injected supracalvarially with
adenovirus expressing LacZ (Ad LacZ) or IKKb
SSEE (Ad IKKb
SSEE), LPS, or RANKL. Arrows indicate areas of osteoclastic bone erosion. Scale bars¼200mm.
(B) Images of H&E-, TRACP-, and immunoperoxidase-phospho-IkBa stained histologic slides of knees of mice injected intraarticularly with adenovirus
expressing LacZ (Ad LacZ) or IKKb
SSEE (Ad IKKb
SSEE). Arrows indicate areas of pathologic osteoclastic bone erosion (pink) at the articular surface. Asterisks
denoteareasofpotentialinflammatorycellinfiltrateintothesynovialspace.ArrowheadsinTRACP-stainedsectionspointtoremnantsofarticularcartilage.
Arrowheadsin lowerpanelshow positivestainfor phosphorylated IkBa. Objectiveusedfor capturingimageis labeledabovepanels. Scale bars¼200mm.
1292 Journal of Bone and Mineral Research OTERO ET AL.Disclosures
All the authors state that they have no conflicts of interest.
Acknowledgments
We thank Drs L Xing for providing the RANK null cells and the NF-
kB double-knockout cells, Y. Choi for providing the RANKL null
mice, D Novack for the RelB null cells, M Pasparakis for the IKKb-
floxed mice, J Vacher for the CD11b-Cre mice, C Idleburg for
superb histology work, and R Aurora for helpful discussions. This
researchwassupportedbyaRuthLKirschsteinPredoctoralGrant
(NRSA: AR055392-01) to JEO, NIH Grants AR049192 and
AR054326 to YA-A, and Grants 8570 and 8510 from the Shriners
Hospital for Children to YA-A.
References
1. Teitelbaum SL. Osteoclasts: what do they do and how do they do it?
Amer J Pathol. 2007;170:427–435.
2. Abu-Amer Y. Advances in osteoclast differentiation and function.
Current drug targets. Immune, endo and metab dis. 2005;5:347–355.
3. Teitelbaum SL, Ross FP. Genetic regulation of osteoclast develop-
ment and function. Nat Rev Genet. 2003;4:638–649.
4. Takayanagi H. Mechanistic insight into osteoclast differentiation in
osteoimmunology. J Mol Med (Berlin, Germany). 2005;83:170–179.
5. Destaing O, Sanjay A, Itzstein C, et al. The tyrosine kinase activity of c-
Src regulates actin dynamics and organization of podosomes in
osteoclasts. Mol Biol Cell. 2008;19:394–404.
6. McHugh KP, Hodivala-Dilke K, Zheng MH, et al. Mice lacking b3-
integrins are osteosclerotic because of dysfunctional osteoclasts.
J Clin Invest. 2000;105:433–440.
7. Zou W, Kitaura H, Reeve J, et al. Syk, c-Src, the avb3-integrin, and
ITAM immunoreceptors, in concert, regulate osteoclastic bone
resorption. J Cell Biol. 2007;176:877–888.
8. Zou W, Reeve JL, Liu Y, Teitelbaum SL, Ross FP. DAP12 couples c-Fms
activation to the osteoclast cytoskeleton by recruitment of Syk. Mol
cell. 2008;31:422–431.
9. Wang Y, Lebowitz D, Sun C, Thang H, Grynpas MD, Glogauer M.
Identifying the relative contributions of Rac1 and Rac2 to osteoclas-
togenesis. J Bone Min Res. 2008;23:260–270.
10. Teitelbaum SL. Bone resorption by osteoclasts. Science (New York).
2000;289:1504–1508.
11. Iotsova V, Caamaa ¨no J, Loy J, Yang Y, Lewin A, Bravo R. Osteopetrosis
in mice lacking NF-kB1 and NF-kB2. Nat Med. 1997;3:1285–1289.
12. Vaira S, Alhawagri M, Anwisye I, Kitaura H, Faccio R, Novack DV. RelA/
p65 promotes osteoclast differentiation by blocking a RANKL-induced
apoptotic JNK pathway in mice. J Clin Invest. 2008;118:2088–2097.
13. Vaira S, Johnson T, Hirbe AC, et al. RelB is the NF-kB subunit down-
stream of NIK responsible for osteoclast differentiation. Proc Natl
Acad Sci USA. 2008;105:3897–3902.
14. Rothwarf DM, Karin M. The NF-kB activation pathway: a paradigm in
information transfer from membrane to nucleus. Science’s STKE.
1999;1999:RE1.
15. He `acker H, Karin M. Regulation and function of IKK and IKK-related
kinases. Science’s STKE. 2006;2006:re13.
16. Rossi A, Kapahi P, Natoli G, et al. Anti-inflammatory cyclopentenone
prostaglandins are direct inhibitors of IkB kinase. Nature.
2000;403:103–118.
17. Dai S, Hirayama T, Abbas S, Abu-Amer Y. The IkB kinase (IKK) inhibitor,
NEMO-binding domain peptide, blocks osteoclastogenesis and
bone erosion in inflammatory arthritis. J Biol Chem. 2004;279:37219–
37222.
18. Jimi E, Aoki K, Saito H, et al. Selective inhibition of NF-kappa B blocks
osteoclastogenesis and prevents inflammatory bone destruction in
vivo. Nat Med. 2004;10:617–624.
19. Chaisson ML, Branstetter DG, Derry JM, et al. Osteoclast differentia-
tion is impaired in the absence of IkB kinase-a. J Biol Chem.
2004;279:54841–54848.
20. Ruocco MG, Maeda S, Park JM, et al. IkB kinase-b, but not IkK-a,
is a critical mediator of osteoclast survival and is required for
inflammation-induced bone loss. J. Exp. Med. 2005;201:1677–
1687.
21. Otero JE, Dai S, Foglia D, et al. Defective osteoclastogenesis by IKKb
null precursors is a result of receptor activator of NF-kB ligand
(RANKL)-induced JNK-dependent apoptosis and impaired differen-
tiation. J Biol Chem. 2008;283:24546–24553.
22. Chiu WS, McManus JF, Notini AJ, Cassady AI, Zajac JD, Davey RA.
TransgenicmicethatexpressCrerecombinaseinosteoclasts.Genesis
(New York, N.Y.: 2000). 2004;39:178–185.
23. PasparakisM,CourtoisG,HafnerM,etal.TNF-mediatedinflammatory
skin disease in mice with epidermis-specific deletion of IKK2. Nature.
2002;417:861–866.
24. Chaisson ML, Branstetter DG, Derry JM, et al. Osteoclast differentia-
tion is impaired in the absence of IkB kinase-a. J Biol Chem.
2004;279:54841–54848.
25. Vaira S, Johnson T, Hirbe AC, et al. RelB is the NF-kB subunit down-
stream of NIK responsible for osteoclast differentiation. Proc Natl
Acad Sci (USA). 2008;105:3897–3902.
26. Hsu H, Lacey DL, Dunstan CR, et al. Tumor necrosis factor receptor
family member RANK mediates osteoclast differentiation and activa-
tion induced by osteoprotegerin ligand. Proc Natl Acad Sci (USA).
1999;96:3540–3545.
27. Yamashita T, Yao Z, Li F, et al. NF-kB p50 and p52 regulate receptor
activator of NF-kB ligand (RANKL) and tumor necrosis factor-induced
osteoclast precursor differentiation by activating c-Fos and NFATc1.
J Biol Chem. 2007;282:18245–18253.
28. Mercurio F, Zhu H, Murray BW, et al. IKK-1 and IKK-2: cytokine-
activated IkB kinases essential for NF-kB activation. Science (New
York, N.Y.). 1997;278:860–866.
29. Delhase M, Hayakawa M, Chen Y, Karin M. Positive and negative
regulation of IkB kinase activity through IKKb subunit phosphoryla-
tion. Science (New York, N.Y.). 1999;284:309–313.
30. Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for
transient packaging of retroviruses. Gene therapy. 2000;7:1063–1066.
31. Anderson RD, Haskell RE, Xia H, Roessler BJ, Davidson BL. A simple
method for the rapid generation of recombinant adenovirus vectors.
Gene therapy. 2000;7:1034–1038.
32. Grigoriadis AE, Wang ZQ, Cecchini MG, et al. c-Fos: a key regulator of
osteoclast-macrophage lineage determination and bone remodel-
ing. Science (New York, N.Y.). 1994;266:443–448.
33. Saftig P, Hunziker E, Wehmeyer O, et al. Impaired osteoclastic bone
resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc
Natl Acad Sci U S A. 1998;95:13453–13458.
34. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology.
2001;142:5050–5055.
35. Rudolph D, Yeh WC, WakehamA, et al. Severe liver degeneration and
lack of NF-kB activation in NEMO/IKKgamma-deficient mice. Genes &
development. 2000;14:854–862.
36. May MJ, Marienfeld RB, Ghosh S. Characterization of the IkB-kinase
NEMO binding domain. J Biol Chem. 2002;277:45992–46000.
37. Hanks SK, Hunter T. Protein kinases 6. The eukaryotic protein kinase
superfamily: kinase (catalytic) domain structure and classification.
FASEB J. 1995;9:576–596.
RANK-INDEPENDENT OSTEOCLASTOGENESIS BY IKKb Journal of Bone and Mineral Research 129338. Senftleben U, Cao Y, Xiao G, et al. Activation by IKKa of a second,
evolutionaryconserved,NF-kBsignaling pathway. Science.2001;293:
1495–1499.
39. Takayanagi H, Kim S, Koga T, et al. Induction and activation of the
transcription factor NFATc1 (NFAT2) integrate RANKL signaling in
terminal differentiation of osteoclasts. Dev Cell. 2002;3:889–901.
40. Bonizzi G, Karin M. The two NF-kB activation pathways and their role in
innate and adaptive immunity. Trends Immunol. 2004; 25:280–288.
41. LamJ,Abu-AmerY,NelsonC,FermontD,RossF,TeitelbaumS.Tumor
necrosisfactorsuperfamilycytokinesandthepathogenesisofinflam-
matory osteolysis. Ann Rheu Dis. 2002;61:82–83.
42. Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL. IL-1 mediates
TNF-induced osteoclastogenesis. J Clin Invest. 2005;115:282–
290.
43. Kim N, Kadono Y, Takami M, et al. Osteoclast differentiation inde-
pendent of the TRANCE-RANK-TRAF6 axis. J Exp Med. 2005;202:589–
595.
44. Simsek S, Basoski NM, Bravenboer N, et al. Sporadic hyperphospha-
tasiasyndromefeaturingperiostitisandacceleratedskeletalturnover
without receptor activator of nuclear factor-kB, osteoprotegerin, or
sequestosome-1 gene defects. J Clin Endo Metab. 2007;92:1897–
1901.
1294 Journal of Bone and Mineral Research OTERO ET AL.